2016 Latin American conference on cardiometabolic diseases management: Health emergencies in focus

Cardiometabolic
Endocrinology and metabolism

Diabetes
Hypertension
Thyroid disorder

Regional conference by Excemed

Friday, Jul 22 - Saturday, Jul 23 2016

São Paulo, Brazil

Language

The official language of the symposium will be English. Simultaneous translation from English to Spanish and Portuguese and vice versa will be provided.

Registration status

Not applicable

To register for this event, contact

Meridiano Congress
Project Coordinator: Titty Alvino
T +39 06 88 595 310 - F +39 06 88595 234
titty.alvino@meridiano.it

Registration fee

200.00€

The registration fee is 200€ and includes:
•   Scientific sessions
•   Coffee breaks and luncheons
•   Educational materials
•   Certificate of attendance

Target audiences

This programme is intended for general practitioners

Cardiologists

Endocrinologists

internists and all other healthcare professionals managing cardiometabolic diseases in Latin America

Files

Final Programme

Introduction

Scroll down to the Scientific Programme below to find hyperlinks to corresponding video lectures and slide presentations.

Overview

Two of the most challenging global health emergencies of the 21st century are diabetes and hypertension. Both can progress to serious cardiovascular conditions which are the leading cause of death in developed countries; high blood pressure is still considered the highest worldwide risk factor for premature death. In 2015 alone, the International Diabetes Federation estimates that 415 million people were affected by diabetes – a number that is expected to rise over the next two decades. Patients with diabetes are at high risk of developing co morbidities which can cause disability, reduced quality of life and a raised risk of mortality. Pathogenesis of diabetes and hypertension is linked to modifiable risk factors such as diet and lifestyle as well as genetic predisposition. Both hypertension and diabetes are reaching epidemic proportions in Central and South America as both regions engage in increasingly Western lifestyles. Thyroid dysfunction, which poses complex medical problems and requires dedicated treatment, is also common in Latin America due to iodine deficiency as well as genetic factors. Even though modern medicine offers a plethora of therapeutic interventions for diabetes, hypertension and thyroid dysfunction, the management of these conditions is still an enormous burden on the global healthcare community – in part due to insufficient funding allocated to combating cardiometabolic diseases.

Learning objectives

• Manage hypertension and related cardiovascular complications

• Apply the suggested algorithms for diabetes management

• Manage thyroid disorders

• Improve the proper use of oral antidiabetic agents in different conditions

• Manage the complexity of the relationship between hypertension, diabetes and thyroid disorders

Accreditation details

An application has been made to the EACCME ® for CME accreditation of the EXCEMED conference 2016 Latin American conference on cardiometabolic diseases management: Health emergencies in focus to be held on 22-23 July 2016 in São Paulo, Brazil.

Scientific programme

Friday, 22 July 2016

08.30 registration

09.00 Welcome and introduction

Session I: Three questions on pre-diabetes

09.15 L1: Diabetes, how do we get there? K. Cruickshank (UK)

Video lecture, Slide presentation

09.40 L2: Lifestyle modifications to prevent diabetes: is it enough? P. L. Jaramillo (Colombia)

Video lecture (in Spanish), Slide presentation

10.05 L3: Drugs for type 2 diabetes prevention: which is better? Leticia Schwerz Weinert

Video lecture (in Portuguese), Slide presentation

10.30 Question time

11.00 coffee break

Session II: Three questions on overt diabetes

11.15 L4: Diabetes management: how to choose the right drug? E. Maddaloni (Italy)

11.40 L5: Gestational Diabetes: when and how should pharmacological intervention be implemented? Leticia Schwerz Weinert

Video lecture (in Portuguese), Slide presentation

12.05 L6: What is the role of new technologies in type 2 diabetes? Anna Rita Maurizi

Video lecture, Slide presentation

12.30 Question time

13.00 Lunch

Session III: Thyroid

14.00 L7: Cardiometabolic implications of thyroid dysfunction, G. Brenta (Argentina)

Video lecture, Slide presentation

14.25 L8: Subclinical hypothyroidism: myths, presumptions and facts, B. Biondi (Italy)

Video lecture, Slide presentation

14.50 L9: New perspectives in the diagnostic of thyroid nodules, G. Brenta (Argentina)

Video lecture, Slide presentation

15.15 Question time

15.45 coffee Break

Session IV: Debate on hot metabolic topics

16.00 Debate on optimizing metformin and combination therapy

Optimizing metform - K. Cruickshank (UK) VS. Combination therapy P. L. Jaramillo (Colombia)

16.20 Let’s talk

Session V: Bridge lecture

16.40 L10: Autonomic dysfunction in diabetes: the hidden diseases complicating blood pressure and heart rate control, V. Spallone (Italy)

Video lecture, Slide presentation

17.05    Question time

17.25    Take home messages

17.30    end of the first day

Saturday, 23 July 2016

Session VI: Specific problems in hypertension

09.00 L11: Are hypertension and obesity linked? G. Grassi (Italy)

Video lecture, Slide presentation

09.25 L12: High heart rate and cardiovascular risk, G. Grassi (Italy)

Video lecture, Slide presentation

09.50 L13: Goal of treating patients with hypertension and coronary artery disease, Speaker to be announced

10.15 Question time

10.45 coffee Break

Session VII: Debate on hot topics in hypertension

11.00 Debate on the management on blood pressure targets in hypertension

Blood pressure targets in hypertension: the evidence for sprint Speaker to be announced

VS.

Blood pressure targets in hypertension: the evidence against sprint G. Grassi (Italy)

11.20 Question time

Session VIII: Hypertension treatment issues

11.40 L14: Is heart rate a target in hypertensive treatment? H. Struijker-Boudier (The Netherlands)

Video lecture, Slide presentation

12.05 L15: combination treatment: RAS blockers are not the only possibility - relevance of combination therapy in hypertension, S. Taddei (Italy)

Video lecture, Slide presentation

12.30 L16: The prevention of heart failure development in hypertension, María Juliana Rodríguez Gonzalez

Video lecture (in Spanish), Slide presentation

12.55    Question time

13.25    Take home messages

13.30    end of the conference

    Closing lunch

CME provider

EXCEMED - Excellence in Medical Education

Senior Programme Manager: Chloé Xilinas
T +39 06 420413 505 - F +39 06 420413 677
chloe.xilinas@excemed.org
Cardiologist Medical Advisor: Stefano Taddei
Endocrinologist Medical Advisor: Ernesto Maddaloni

Speakers